Cleared Traditional

K192590 - CURA 778

K192590 is the FDA 510(k) clearance for CURA 778 by Fmi Medical Systems, Inc.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 167-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
167d
Days
Class 2
Risk

K192590 is an FDA 510(k) clearance for the CURA 778. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Fmi Medical Systems, Inc. (Solon, US). The FDA issued a Cleared decision on March 5, 2020 after a review of 167 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fmi Medical Systems, Inc. devices

Submission Details

510(k) Number K192590 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2019
Decision Date March 05, 2020
Days to Decision 167 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 107d · This submission: 167d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K192590.
syngo.CT Cardiac Planning
K200515 · Siemens Medical Soultions USA, Inc. · Mar 2020
Hepatic VCAR
K193281 · GE Medical Systems SCS · Mar 2020
Al-Rad Companion (Musculoskeletal)
K193267 · Siemens Medical Solutions USA, Inc. · Mar 2020
Broncholab
K191550 · Fluidda, Inc. · Mar 2020
uCT 530, uCT 550
K200016 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2020
Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i
K192832 · Canon Medical Systems Corporation · Feb 2020